Mode
Text Size
Log in / Sign up
N/A Completed N=39 Randomized Single-blind Prevention

MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback

Source: ClinicalTrials.gov NCT03820024 ↗
Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Jul 2021
Primary outcomePrimary: Change in Steps in Endometrial Cancer Survivors During 12 Week Intervention — 1037; 309 Change in steps

Summary

Overweight and obese endometrial cancer (EC) survivors at the University of North Carolina (UNC) at Chapel Hill will be approached for tailored feedback fitness intervention. The investigators plan to enroll 36 women (18 in each arm) to evaluate if receipt of weekly tailored feedback messages can improve physical activity in EC survivors. It is hypothesized that women receiving the feedback message intervention will increase step counts from baseline more than 2,000 steps compared to women in the non-intervention arm.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Steps in Endometrial Cancer Survivors During 12 Week Intervention
1037; 309

Eligibility Criteria

Inclusion Criteria

  • Be over the age of 18 years
  • Have a confirmed diagnosis of endometrial cancer and have completed therapy (surgery, chemotherapy or radiation) within the past 6 months
  • Have no current evidence of endometrial cancer
  • Have a BMI 25 kg/m2 or greater
  • Have approval from their treating physician to engage in moderate-intensity physical activity.
  • Have a smart phone with Bluetooth capabilities turned on
  • Have access to email

Exclusion Criteria

  • Are currently undergoing treatment for their cancer
  • Are unable to read a sample message aloud
  • Do not have a computer or smart phone with Bluetooth capabilities
  • Are pregnant
  • Have a history of angina or palpitations with exertion
  • Have a history of uncontrolled pulmonary disease (COPD or asthma)
  • Have one or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03820024). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search